Secukinumab is effective in treatment of moderate to severe plaque psoriasis: Real-life effectiveness and safety from the PROSPECT study
Journal of the European Academy of Dermatology and Venereology | Sep 29, 2019
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients
Journal of the European Academy of Dermatology and Venereology | Sep 26, 2019
Most read this week